Annual EBIT
-$134.25 M
-$4.61 M-3.56%
December 31, 2023
Summary
- As of February 8, 2025, IPSC annual earnings before interest & taxes is -$134.25 million, with the most recent change of -$4.61 million (-3.56%) on December 31, 2023.
- During the last 3 years, IPSC annual EBIT has fallen by -$80.97 million (-151.95%).
- IPSC annual EBIT is now -151.95% below its all-time high of -$53.29 million, reached on December 31, 2020.
Performance
IPSC EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$31.23 M
-$49.00 K-0.16%
September 30, 2024
Summary
- As of February 8, 2025, IPSC quarterly earnings before interest & taxes is -$31.23 million, with the most recent change of -$49.00 thousand (-0.16%) on September 30, 2024.
- Over the past year, IPSC quarterly EBIT has increased by +$894.00 thousand (+2.78%).
- IPSC quarterly EBIT is now -222.90% below its all-time high of -$9.67 million, reached on March 31, 2020.
Performance
IPSC Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$130.75 M
+$894.00 K+0.68%
September 30, 2024
Summary
- As of February 8, 2025, IPSC TTM earnings before interest & taxes is -$130.75 million, with the most recent change of +$894.00 thousand (+0.68%) on September 30, 2024.
- Over the past year, IPSC TTM EBIT has dropped by -$5.47 million (-4.37%).
- IPSC TTM EBIT is now -1251.67% below its all-time high of -$9.67 million, reached on March 31, 2020.
Performance
IPSC TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
IPSC EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -3.6% | +2.8% | -4.4% |
| 3 y3 years | -151.9% | +3.0% | -5.8% |
| 5 y5 years | +45.1% | +3.0% | -5.8% |
IPSC EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -41.6% | at low | -11.9% | +22.4% | -37.9% | +2.6% |
| 5 y | 5-year | -151.9% | +45.1% | -222.9% | +22.4% | -1251.7% | +2.6% |
| alltime | all time | -151.9% | +45.1% | -222.9% | +22.4% | -1251.7% | +2.6% |
Century Therapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$31.23 M(+0.2%) | -$130.75 M(-0.7%) |
| Jun 2024 | - | -$31.18 M(+11.1%) | -$131.64 M(-0.8%) |
| Mar 2024 | - | -$28.06 M(-30.3%) | -$132.66 M(-1.2%) |
| Dec 2023 | -$134.25 M(+3.6%) | -$40.27 M(+25.3%) | -$134.31 M(+7.2%) |
| Sep 2023 | - | -$32.13 M(-0.2%) | -$125.28 M(+1.4%) |
| Jun 2023 | - | -$32.20 M(+8.4%) | -$123.58 M(+1.2%) |
| Mar 2023 | - | -$29.71 M(-4.9%) | -$122.09 M(-5.8%) |
| Dec 2022 | -$129.64 M | -$31.24 M(+2.7%) | -$129.64 M(+2.6%) |
| Sep 2022 | - | -$30.43 M(-0.9%) | -$126.31 M(+3.8%) |
| Jun 2022 | - | -$30.72 M(-17.6%) | -$121.65 M(+6.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$37.26 M(+33.5%) | -$113.96 M(+20.2%) |
| Dec 2021 | -$94.81 M(+77.9%) | -$27.91 M(+8.3%) | -$94.81 M(+15.4%) |
| Sep 2021 | - | -$25.76 M(+11.9%) | -$82.19 M(+18.3%) |
| Jun 2021 | - | -$23.03 M(+27.2%) | -$69.45 M(+12.5%) |
| Mar 2021 | - | -$18.11 M(+18.5%) | -$61.72 M(+15.8%) |
| Dec 2020 | -$53.29 M(-78.2%) | -$15.29 M(+17.4%) | -$53.29 M(+40.2%) |
| Sep 2020 | - | -$13.03 M(-14.9%) | -$38.00 M(+52.2%) |
| Jun 2020 | - | -$15.30 M(+58.2%) | -$24.97 M(+158.2%) |
| Mar 2020 | - | -$9.67 M | -$9.67 M |
| Dec 2019 | -$244.77 M | - | - |
FAQ
- What is Century Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Century Therapeutics?
- What is Century Therapeutics annual EBIT year-on-year change?
- What is Century Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Century Therapeutics?
- What is Century Therapeutics quarterly EBIT year-on-year change?
- What is Century Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Century Therapeutics?
- What is Century Therapeutics TTM EBIT year-on-year change?
What is Century Therapeutics annual earnings before interest & taxes?
The current annual EBIT of IPSC is -$134.25 M
What is the all time high annual EBIT for Century Therapeutics?
Century Therapeutics all-time high annual earnings before interest & taxes is -$53.29 M
What is Century Therapeutics annual EBIT year-on-year change?
Over the past year, IPSC annual earnings before interest & taxes has changed by -$4.61 M (-3.56%)
What is Century Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of IPSC is -$31.23 M
What is the all time high quarterly EBIT for Century Therapeutics?
Century Therapeutics all-time high quarterly earnings before interest & taxes is -$9.67 M
What is Century Therapeutics quarterly EBIT year-on-year change?
Over the past year, IPSC quarterly earnings before interest & taxes has changed by +$894.00 K (+2.78%)
What is Century Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of IPSC is -$130.75 M
What is the all time high TTM EBIT for Century Therapeutics?
Century Therapeutics all-time high TTM earnings before interest & taxes is -$9.67 M
What is Century Therapeutics TTM EBIT year-on-year change?
Over the past year, IPSC TTM earnings before interest & taxes has changed by -$5.47 M (-4.37%)